| Filed | Form | Description | |
|---|---|---|---|
| 2/9/24 | SC 13G/A | SC 13G/A | → |
| 2/8/24 | SC 13G/A | AMENDMENT TO SC 13G | → |
| 2/2/24 | SC 13G/A | SCHEDULE 13G/A | → |
| 1/29/24 | SC 13G/A | SC 13G/A | → |
| 11/16/23 | SC 13G | SC 13G | → |
| 11/8/23 | SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | → |
| ↓ | |||
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts.